[1]
„CUT OFF VALUE OF PROCALCITONIN IN END STAGE RENAL DISEASE PATIENTS WITHOUT INFECTION“, Pak J Kidney Dis, Bd. 5, Nr. 02, S. 48–53, Juni 2021, doi: 10.53778/pjkd502144.